J.ophthalmol.(Ukraine).2018;1:78-80.

https://doi.org/10.31288/oftalmolzh201817880

Characteristics of measles keratoconjunctivitis in adults

O.N. Ivanova, Cand. Sc. (Med.), T.B. Gaydamaka, Dr. Sc. (Med.), G.I. Drozhzhyna, Dr. Sc. (Med.), T.A. Veliksar, Postgraduate Student

Filatov Institute of Eye Diseases and Tissue Therapy, NAMS of Ukraine; Odessa (Ukraine)

E-mail: tveliksar@gmail.com          

Introduction.  Measles (lat. morbilli) is an acute anthroponotic infectious virus disease with a high contagion level. In general, measles is common for children. However, there are a good number of the diseased among adults. A clinical picture of measles in adults is characterized by more intensive symptoms and by more likely development of complications.

Purpose. To analyze the clinical course of measles keratoconjunctivitis in adults.

Materials and Methods. In 2017, we followed up two patients (aged 34 and 42) having had measles with an atypical disease course. Both patients were diagnosed bilateral conjunctivitis and superficial punctate keratitis. Dry eye syndrome was moderate. The patients were performed anti-inflammatory, antiviral, desensitizing and substitutional therapy. 3 days after treatment onset, the patients' complaints decreased and biomicroscopy findings were improved. At Day 7, the subjective complaints and clinical signs almost disappeared.

Conclusion. The course of measles in adults is of particular severity. Measles keratoconjunctivitis is characterized by punctuate eruption in the cornea and pronounced dry eye syndrome. Early therapy enabled to regress the process and to recover the vision within a short period of time.

Key-words: keratitis, measles, keratoconjunctivitis, epitheliopathy        

References

  1. Ivanova VV. [Guidance for paediatric infections]. SPb. 2002. Russian. 
  2. News-bulletin N°286 «Measles».  WHO. 2013.
  3. Order of the Ministry of Health No 125 from 21 March 2014 “Concerning Approval of the National Calendar of Prophylactic Immunization and Epidemic National Calendar of Prophylactic Immunization”. With amendments and additions to 16 June 2016.  Russian.
  4. Simovanyan EN. [Infectious diseases in children]. M; 2007. Russian. 
  5. Tatochenko VK, Ozeretskovskii NA, Fedorov AM et al. [Immunologic prophylaxis] M; 2009: 12-3. Russian. 
  6. Uchaikin VF, Nisyevich NI, Shamsheva OV. [Infectious diseases in children]. M.:Meditsina; 2006. Russian.
  7. Giladi M, Schuman A, Kedem R, Danon YL. Measles in adults: a prospective study of 291 consecutive cases. Br Med J (Clin Res Ed). 1987;295(6609):1314. PMCID: PMC1248383.
    Crossref   Pubmed
  8. Kayikçioglu O, Kir E, Söyler M et al. Ocular findings in a measles epidemic among young adults.Ocul. Immunol. Inflamm. 2000; 8(1):59-62.
    Crossref   Pubmed
  9. Leibovichi L, Sharir T, Kalter-Leibovichi O et al. An outbreak of measles among young adults: Clinical and laboratory features in 461 patients. Journal of Adolescent Health Care. 1988;9(3):203-7.
    Crossref   Pubmed
  10. Measles vaccines: WHO position paper. Releve epidemiologique hebdomadaire. Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record. Health Section of the Secretariat of the League of Nations. 2009;84(35):349-360.
  11. Moss WJ, Griffin DE.  Measles. Lancet. 2012;379(9811):153-64.
    Crossref   Pubmed
  12. Végh M, Hári-Kovács A, Roth HW, Facskó A. Ophthalmological symptoms of measles and their treatment. Orv Hetil. 2017;158(39):1523-7. 
    Crossref   Pubmed